文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

抗反流手术后医疗支出与利用:再入院原因及费用分析

Healthcare spending and utilization following antireflux surgery: examining costs and reasons for readmission.
PubMed 文献 · Surg Endosc · 2019-04-05

基于Truven Health MarketScan数据库分析2012-2014年40,853例抗反流手术患者,平均年龄49岁、女性76.0%,93.0%为腹腔镜入路。术后90天内再入院率4.2%,再入院者额外费用29,513美元,使总费用近乎翻倍;急诊就诊率14.0%,门诊内镜检查1.5%。

要点

  • 抗反流术后90天内再入院率为4.2%,再入院者中26.3%需外科干预。
  • 再入院额外费用29,513美元,使总体医疗费用近乎翻倍。
  • 常见再入院原因与营养、代谢及水电解质紊乱相关。

核心结论

  • 多数抗反流手术患者术后90天内无需额外医疗照护,但再入院者费用近乎翻倍。

研究设计与样本

  • 基于Truven Health MarketScan数据库的回顾性队列研究,纳入2012-2014年40,853例因GERD行抗反流手术(胃底折叠术和/或食管旁疝修补)且年龄>16岁的患者。

主要发现

  • 平均住院日1.4天,93.0%为腹腔镜入路,初始手术住院平均费用24,034美元。
  • 再入院率4.2%,再入院者中26.3%需外科干预,额外费用29,513美元。
  • 急诊就诊率14.0%,门诊上消化道内镜检查率1.5%,相关费用1,175美元,远低于再入院费用。
  • 常见再入院原因与营养、代谢及水电解质紊乱相关。

临床怎么用

  • 关注抗反流术后营养、代谢及水电解质紊乱,可能有助于减少可预防的再入院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While clinical outcomes have been reported for anti-reflux surgery (ARS), there are limited data on post-operative encounters, including readmission, and their associated costs. This study evaluates healthcare utilization during the 90-day post-operative period following ARS including fundoplication and/or paraesophageal hernia (PEH) repair. METHODS: Data were analyzed from the Truven Health MarketScan® Databases. Patients older than 16 years with an ICD-9 procedure code or Common Procedural Terminology (CPT) code for ARS and a primary diagnosis of GERD during 2012-2014 were selected. Healthcare spending and utilization on emergency department (ED) visits, performance of outpatient endoscopy, and readmission were examined. Reasons for readmission were classified based on ICD-9 code. RESULTS: A total of 40,853 patients were included in the cohort with a mean age of 49 years and females comprising 76.0%. Mean length of stay was 1.4 days, and 93.0% of patients underwent a laparoscopic approach. The mean cost of the index surgical admission was $24,034. Readmission occurred in 4.2% of patients, and of those, 26.3% required a surgical intervention. Patients requiring one or more related readmissions accrued additional costs of $29,513. Some of the most common reasons for readmission were related to nutritional, metabolic, and fluid and electrolyte disorders. Presentation to the ED occurred in 14.0% of patients, and outpatient upper endoscopy was required in 1.5% of patients, but with much lower associated costs as compared to readmission ($1175). CONCLUSION: The majority of patients undergoing ARS do not require additional care within 90 days of surgery. Patients who are readmitted accrue costs that almost double the overall cost of care compared to the initial hospitalization. Measures to attenuate potentially preventable readmissions after ARS may reduce healthcare utilization in this patient population.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kleppe KL, Xu Y, Funk LM, et al. Healthcare spending and utilization following antireflux surgery: examining costs and reasons for readmission. Surg Endosc. 2019. PMID: 30953200. doi:10.1007/s00464-019-06758-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。